Global Insomnia Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Insomnia Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
Global Insomnia Therapy market is projected to reach US$ 4147.8 million in 2033, increasing from US$ 2900 million in 2022, with the CAGR of 5.2% during the period of 2023 to 2033. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Insomnia Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Segment by Type
Non-pharmacological Therapy
Pharmacological Therapy
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insomnia Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Insomnia Therapy introduction, etc. Insomnia Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Insomnia Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Global Insomnia Therapy market is projected to reach US$ 4147.8 million in 2033, increasing from US$ 2900 million in 2022, with the CAGR of 5.2% during the period of 2023 to 2033. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Insomnia Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Segment by Type
Non-pharmacological Therapy
Pharmacological Therapy
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insomnia Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Insomnia Therapy introduction, etc. Insomnia Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Insomnia Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.